Makers Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Makers Laboratories Ltd · Outcome · 04 Nov 2026, 5:51 pm
Makers Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 4,821 (+41.1% YoY | +12.7% QoQ) ■ EBITDA: 1,210 (+429.3% YoY | +73.8% QoQ) ■ EBITDA Margin (%): 25.1 (+1841 bps YoY | +882 bps QoQ) ■ PAT: 395 (Loss to Profit YoY | +162.6% QoQ) ■ EPS (INR): 6.69 (Loss to Profit YoY | +162.4% QoQ) Makers Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Pharmaceutical ■ Revenue: 1,393 (+10.2% YoY | +35.7% QoQ) ■ EBIT: 36.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 2.6 (Loss to Profit YoY | Loss to Profit QoQ) Chemical Manufacturing ■ Revenue: 3,503 (+60.0% YoY | +5.8% QoQ) ■ EBIT: 1,119 (+402.1% YoY | +48.1% QoQ) ■ EBIT Margin (%): 31.9 (+2176 bps YoY | +913 bps QoQ)
Original exchange filing (PDF)
More announcements from Makers Laboratories Ltd
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 · 04 Nov 2026
- Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Standalone and Consolidated .... · 04 Nov 2026
- Credit Rating for Bank Facilities · 01 Sept 2026
- Voting Results and Scrutinizer Report · 07 Aug 2026
- 41st Annual General Meeting of the Company · 07 Aug 2026
- Change in Directorship of Mr. Saahil Parikh from Wholetime Director to Non-Executive, Non-Independent Wholetime Director · 07 Aug 2026
- Standalone and Consolidated Financial Results for Q1FY27 · 07 Aug 2026
- Outcome of Board Meeting · 07 Aug 2026
